New approaches to obstetric hemorrhage: The postpartum hemorrhage consensus algorithm

Current Opinion in Anaesthesiology

Volumn 27, Issue 3, 2014, Pages 267-274

  Girard, Thierry ^a   Mörtl, Manfred ^b   Schlembach, Dietmar ^c  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Interdisciplinary Centre for Gynecology Gynecooncology and Feto Maternal Medicine   (Austria)

^c JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Massive bleeding; postpartum hemorrhage; uterine atony

Indexed keywords

ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 7; CARBETOCIN; FIBRINOGEN; FRESH FROZEN PLASMA; OXYTOCIN; RECOMBINANT ACTIVATED BLOOD CLOTTING FACTOR 7; SULPROSTONE; TRANEXAMIC ACID; UNCLASSIFIED DRUG;

ACIDOSIS; ADVERSE OUTCOME; ALGORITHM; AMNION FLUID EMBOLISM; ANEMIA; BLOOD CLOTTING DISORDER; CESAREAN SECTION; CLINICAL PRACTICE; DISSEMINATED INTRAVASCULAR CLOTTING; EMERGENCY SURGERY; ERYTHROCYTE; FIBRIN POLYMERIZATION; FIBRINOLYSIS; HELLP SYNDROME; HEMODYNAMICS; HEMORRHAGIC SHOCK; HUMAN; HYPOTHERMIA; HYPOVOLEMIA; HYSTERECTOMY; INTERDISCIPLINARY COMMUNICATION; LACERATION; LAPAROTOMY; MANUAL PLACENTAL DELIVERY; PARTIAL THROMBOPLASTIN TIME; POSTPARTUM HEMORRHAGE; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; UTERINE ATONY; UTERINE TAMPONADE; UTERUS INVERSION; UTERUS RUPTURE; ADULT; CONSENSUS; FEMALE; PREGNANCY;

ADULT; ALGORITHMS; CONSENSUS; FEMALE; HUMANS; POSTPARTUM HEMORRHAGE; PREGNANCY;

EID: 84900402769     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0000000000000081     Document Type: Review

References (44)

1. Samangaya R, Pennington R, Vause S. Factors relating to a rising incidence of major postpartum haemorrhage. BJOG 2010; 117:370.
2. RCOG. Green-top Guideline No. 52 [Internet]. [Cited 3 February 2014]. Available at http://www.rcog.org.uk/files/rcog-corp/GT52PostpartumHaemor rhage0411.pdf.
3. Haeri S, Dildy GA. Maternal mortality from hemorrhage. Semin Perinatol 2012; 36:48-55.
4. Farquhar C, Sadler L, Masson V, et al. Beyond the numbers: Classifying contributory factors and potentially avoidable maternal deaths in New Zealand, 2006- 2009. Am J Obstet Gynecol 2011; 205:331. e1-331.e8.
5. Driessen M Bouvier-Colle M-H Dupont C et al. Postpartum hemorrhage resulting from uterine atony after vaginal delivery: Factors associated with severity. Obstet Gynecol 2011 117 21-3 1.
6. Upadhyay K, Scholefield H. Risk management and medicolegal issues related to postpartum haemorrhage. Best Pract Res Clin Obstet Gynaecol 2008; 22:1149-1169.
7. Dupont C, Touzet S, Colin C, et al. Incidence and management of postpartum haemorrhage following the dissemination of guidelines in a network of 16 maternity units in France. Int J Obstet Anesth 2009; 18:320-327.
8. Mercier FJ, Bonnet M-P. Use of clotting factors and other prohemostatic drugs for obstetric hemorrhage. Curr Opin Anaesthesiol 2010; 23:310-316.
9. Snegovskikh D, Clebone A, N orwitz E. Anesthetic management of patients with placenta accreta and resuscitation strategies for associated massive hemorrhage. Curr Opin Anaesthesiol 2011; 24:274-281.
10. Henrich W, Surbek D, Kainer F, et al. Diagnosis and treatment of peripartum bleeding. J Perinat Med 2008; 36:467-478.
11. Kadri Al HMF, Anazi Al BK, Tamim HM. Vis ual estimation versus gravimetric measurement of postpartum blood loss: A prospective cohort study. Arch Gynecol Obstet 2011; 283:1207-1213.
12. Prata N, Gerdts C. Measurement of postpartum blood loss. BMJ 2010; 340:c555.
13. Schorn MN. Measurement of blood loss: Review of the literature. J Midwifery Womens Health 2010; 55:20-27.
14. Kozek-Langenecker SA, A fshari A, Albaladejo P, et al. Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013; 30:270-382. These guidelines of the European Society of Anaest hesiology summarize the different methods to prevent transfusions as well as the possibilities for treatment in many different clinical scenarios.
15. Bolliger D, Görlinger K, Tanaka KA. Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology 2010; 113:1205-1219.
16. Anderson JM, Etches D. Prevention and management of postpartum hemorrhage. Am Fam Physician 2007; 75:875-882.
17. Thomas JS, Koh SH, Cooper GM. Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing caesarean section. Br J Anaesth 2006; 98:116-119.
18. Moertl MG, Friedrich S, Kraschl J, et al. Haemodynamic effects of carbetocin and oxytocin given as intravenous bolus on women undergoing caesarean delivery: A randomised trial. BJOG 2011; 118:1349-1356.
19. International Federation of Gynecology And Obstetrics. Treatment of postpartum hemorrhage with misoprostol. Int J Gynaecol Obstet 2012; 119:215-216.
20. Tang J, Kapp N, Dragoman M, De Souza JP. WHO recommendations for misoprostol use for obstetric and gynecologic indications. Int J Gynaecol Obstet 2013; 121:186-189. Given the controversies about misoprostol, these recommendations are very welcome to clarify the current position of obstetric experts.
21. Hellgren M. Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost 2003; 29:125-130.
22. Levy JH, Dutton RP, Hemph ill JC, et al. Multidisciplinary approach to the challenge of hemostasis. Anesth Analg 2010; 110:354-364.
23. Karlsson O, Jeppsson A, Hellgren M. Major obstetric haemorrhage: Monitoring with thromboelastography, laboratory analyses or both Int J Obstet Anesth 2014; 23:10-17.
24. Macafee BB, Yentis SM, Campbell JPJ, et al. Reference ranges for thromboelastography (TEG) and traditional coagulation tests in term parturients undergoing caesarean section under spinal anaesthesia. Anaesthesia 2012; 67:741-747. As a result of the hypercoagulability toward the end of pregnancy, it is important to define normal values of term pregnant women.
25. Huissoud C, Carrabin N, Audibert F, et al. Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry. BJOG 2009; 116:1097-1102.
26. Dunn CJ Goa KL. Tranexamic acid: A review of its use in surgery and other indications. Drugs 1999 57 1005-1032.
27. Ducloy-Bouthors A-S, Huissoud C, Jude B, et al. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care 2011; 15:R117-R127.
28. Shakur H, Elbourne D, Gu ̈lmezoglu M, et al. The WOMAN Trial (World Maternal Antifibrinolytic Trial): Tranexamic acid for the treatment of postpartum haemorrhage: An international randomised, double blind placeb o controlled trial. Trials 2010; 11:40.
29. Shaz BH, Dente CJ, Nicholas J, et al. Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients. Transfusion 2010; 50:493-500.
30. Pasquier P, Gayat E, Rackelboom T, et al. An observational study of the fresh frozen plasma: Red blood cell ratio in postpartum hemorrhage. Anesth Analg 2013; 116:155-161.
31. Spahn DR, Ganter MT. Towards early individual goal-directed coagulation management in trauma patients. Br J Anaesth 2010; 105:103-105.
32. Kozek-Langenecker S, Sorensen B, Hess J, Spahn DR. Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: A systematic review. Crit Care 2011; 15:R239.
33. . Levy JH, Welsby I, Goodnough LT. Fibrinogen as a therapeutic target for bleeding: A review of critical levels and replacement therapy. Transfusion 2014. [Epub ahead of print]
34. Fries D, Martini WZ. Role of fibrinogen in trauma-induced coagulopathy. Br J Anaesth 2010; 105:116-121.
35. Cortet M, Deneux-Tharaux C, Dupont C, et al. Association between fibrinogen level and severity of post partum haemorrhage: Secondary analysis of a prospective trial. Br J Anaesth 2012; 108:984-989.
36. Charbit B, Mandelbrot L, Samain E, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007; 5:266-273.
37. Rahe-Meyer N, Solomon C, Hanke A, et al. Effects of fibrinogen concentrate as first-line therapy during major aortic re placement surgery: A randomized, placebo-controlled trial. Anesthesiology 2013; 118:40-50.
38. Wikkelsoe AJ, Afshari A, Stensballe J, et al. The FIB-PPH trial: Fibrinogen concentrate as initial treatment for postpartum haemorrhage: Study protocol for a randomised controlled trial. Trials 2012; 13:110.
39. Ahonen J. The role of recombinant activated factor VII in obstetric hemorrhage. Curr Opin Anaesthesiol 2012; 25:309-314.
40. Forna F, Miles AM, Jamieson DJ. Emergency peripartum hysterectomy: A comparison of cesarean and postpartum hysterectomy. Am J Obstet Gynecol 2004; 190:1440-1444.
41. Lau WC, Fung HY, Rogers MS. Ten years experience of caesarean a nd postpartum hysterectomy in a teaching hospital in Hong Kong. Eur J Obstet Gynecol Reprod Biol 1997; 74:133-137.
42. Rath W, Hackethal A, Bohlmann MK. Second-line treatment of postpartum haemorrhage (PPH). Arch Gynecol Obstet 2012; 286:549-561.
43. Merié n AER, Van De Ven J, Mol BW, et al. Multidisciplinary team training in a simulation setting for acute obstetric emergencies: A systemati c review. Obstet Gynecol 2010; 115:1021-1031.
44. Crofts JF, Ellis D, Draycott TJ, et al. Change in knowledge of midwives and obstetricians following obstetric emergency training: A randomised c ontrolled trial of local hospital, simulation centre and teamwork training. BJOG 2007; 114:1534-1541.